ELISE PLAUTZ: Open Payments
NPI 1023661923 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 24 payments from 15 companies in 2025. Trend: 2023 $208 · 2024 $239 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $82 |
| BridgeBio Pharma, Inc. | 3 | $76 |
| Boston Scientific Corporation | 1 | $51 |
| Novo Nordisk Inc | 3 | $46 |
| Abbott Laboratories | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| CVRx, Inc. | 2 | $28 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: Attruby, WATCHMAN FLX, Wegovy, XIENCE SKYPOINT, AMVUTTRA, CAMZYOS, Barostim Neo System, Optimizer.
Industry payments across NE — which companies pay providers there.
